Neurocrine Bioscience buy Royal Bank of Canada
Start price
14.04.25
/
50%
€83.38
Target price
14.04.26
€120.31
Performance (%)
34.92%
Price
13.08.25
€112.50
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Neurocrine Bioscience has seen massive gains of 34.92%. This prediction currently runs until 14.04.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -0.451% | -0.451% |
| iShares Core DAX® | 1.061% | -0.453% |
| iShares Nasdaq 100 | 2.615% | 4.747% |
| iShares Nikkei 225® | 5.693% | 9.002% |
| iShares S&P 500 | 1.433% | 3.156% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating. They now have a $137.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.45
31.07.25
31.07.25
€125.97
31.07.26
31.07.26
0.04%
13.08.25
13.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€108.85
02.06.25
02.06.25
€127.53
02.06.26
02.06.26
3.35%
13.08.25
13.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.90
06.05.25
06.05.25
€128.38
06.05.26
06.05.26
6.23%
13.08.25
13.08.25